CSNK1A1 and intestinal cancer: For instance, Kadosh et al. uncovered that the frequently occurring p53R172H gain-of-function mutation could impose both tumor-suppressive and oncogenic effects in mouse models of Wnt-driven intestinal cancer (generated by Csnk1a1 (encoding CKIα) deletion or APCmin mutation) [138].